-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ao6EO3ltYUqGzD+I5G607B8beYe4lxxZsZBZO/Hu4AsbTtMUhC+nB3BWvtjFkx5j 0MjPtr+JJ/ljNFCqYbFDYw== 0000898822-07-001297.txt : 20071030 0000898822-07-001297.hdr.sgml : 20071030 20071030214125 ACCESSION NUMBER: 0000898822-07-001297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20071026 FILED AS OF DATE: 20071030 DATE AS OF CHANGE: 20071030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BURZIK CATHERINE M CENTRAL INDEX KEY: 0001261141 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04105 FILM NUMBER: 071200989 BUSINESS ADDRESS: STREET 1: C/O APPLERA CORP APPLIED BIOSYSTEMS GR STREET 2: 850 LINCOLN CENTE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BAUSCH & LOMB INC CENTRAL INDEX KEY: 0000010427 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 160345235 STATE OF INCORPORATION: NY FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: BAUSCH & LOMB INCORPORATED STREET 2: ONE BAUSCH & LOMB PLACE CITY: ROCHESTER STATE: NY ZIP: 14604-2701 BUSINESS PHONE: 5853386000 MAIL ADDRESS: STREET 1: ONE BAUSCH & LOMB PLACE STREET 2: P O BOX 54 CITY: ROCHESTER STATE: NY ZIP: 14604-2701 4 1 burzik_ex.xml X0202 4 2007-10-26 1 0000010427 BAUSCH & LOMB INC BOL 0001261141 BURZIK CATHERINE M 1 0 0 0 See Footnote 1 2007-10-26 4 J 0 0 A n/a 0 0 I See Footnote 1 During the 2006-2007 time period, the issuer did not have a current prospectus under its registration statement on Form S-8 covering the issuance of stock to directors. As a result, director fees that were payable in stock and formula-based stock options were not awarded to directors, including the reporting peron, during that period. The reporting person will receive cash compensation based on the $65 per share merger consideration in lieu of stock-denominated fees and formula-based stock option grants which would have been awarded to directors in the ordinary course of business during the 2006-2007 time period under the issuer's compensation plans. /s/ Robert D. Bailey, attorney-in-fact 2007-10-30 EX-24 2 poacmb.txt POWER OF ATTORNEY POWER OF ATTORNEY The undersigned appoints A. Robert D. Bailey, Jean F. Geisel, Jurij Z. Kushner, Stephen C. McCluski and Robert B. Stiles, or any one of them, his or her respective true and lawful attorneys and agents, each with full power and authority to act as such without the other, to sign for and on behalf of the undersigned any Forms 3, 4, 5 or 144 required to be filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934 and the related rules and regulations thereunder, and any amendment or amendments thereto, the undersigned hereby ratifying and confirming all that said attorneys and agents, or either one of them, shall do or cause to be done by virtue hereof. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this instrument has been executed by the undersigned as of this 20th day of February, 2007. /s/ Catherine M. Burzik (Signature) Catherine M. Burzik (Type or Print Name) -----END PRIVACY-ENHANCED MESSAGE-----